Sho Otsuki

Sho Otsuki

Auto-generated profile, based on publicly available information

Sho Otsuki

Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Gastric Cancer
Verified
Journal Article
Open access
YSYuya Sato
Yuya Sato
HKHitoshi Katai
Hitoshi Katai
MIMaiko Ito
Maiko Ito
MYMasahiro Yura
Masahiro Yura
SOSho Otsuki
Sho Otsuki
SMShinji Morita
Shinji Morita
Sato Y, et al. J Gastric Cancer. 2018 Aug;18:e33. https://doi.org/10.5230/jgc.2018.18.e33

1 August 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
YYYukinori Yamagata
Yukinori Yamagata
TYTakaki Yoshikawa
Takaki Yoshikawa
KIKenichi Ishizu
Kenichi Ishizu
AKAyako Kamiya
Ayako Kamiya
TWTakeyuki Wada
Takeyuki Wada
HKHitoshi Katai
Hitoshi Katai

25 September 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MYMasahiro Yura
Masahiro Yura
TYTakaki Yoshikawa
Takaki Yoshikawa
TWTakeyuki Wada
Takeyuki Wada
SOSho Otsuki
Sho Otsuki
THTsutomu Hayashi
Tsutomu Hayashi
TNToshirou Nishida
Toshirou Nishida
Background: Advanced gastric cancer sometimes causes macroscopic serosal change (MSC) due to direct invasion or inflammation. However, the prognostic significance of MSC remains unclear. Methods: A total of 1410 patients who had been diagnosed with deeper-than-pathological-T2 gastric cancer and undergone R0 gastrectomy with lymph node dissection at the National Cancer Center Hospital during January 2000 and December 2012 were restrospectively reviewed. Results: MSC was not found in 108 of the 506 patients with pathological T4a (21.3%), whereas it was detected in 250 of the 904 patients with pathological T2-T3 (27.7%). The sensitivity, specificity and accuracy for diagnosing pathological serosa exposed (SE) by MSC were 78.7, 72.3 and 74.6%, respectively. The MSC-positive cases had a worse 5-year overall survival (OS) than the MSC-negative cases in pT3 (72.9% vs. 84.3%, p = 0.001), pT4a (56.2% vs. 73.4%, p = 0.001), pStageIIB (76.0% vs. 88.4%, p = 0.005), pStageIIIA (63.4% vs. 75.6%, p = 0.019), pStageIIIB (53.6% vs. 69.2%, p = 0.029) and pStage IIIC (27.6% vs. 50.0%, p = 0.062). A multivariate analysis showed that MSC was a significant independent predictor for the OS (hazard ratio [HR]: 1.587, 95%CI 1.209–2.083, p = 0.001) along with the tumor depth (HR: 7.742, 95%CI: 2.935–20.421, p < 0.001), nodal status (HR:5.783, 95% CI 3.985–8.391, p < 0.001) and age (HR:2.382, 95%CI: 1.918–2.957, p < 0.001). Peritoneal recurrence rates were higher in the MSC-positive cases than in the MSC-negative cases at each pT stage. Conclusions: In this study, the MSC was one of the independent prognostic factors in patients with resectable locally advanced gastric cancer.

21 December 2017 in Scandinavian Journal of Surgery
Verified
Journal Article
Open access
MNM. Nakagawa
M. Nakagawa
CTC. Tomii
C. Tomii
MIMikito Inokuchi
Mikito Inokuchi
SOS. Otsuki
S. Otsuki
KKK. Kojima
K. Kojima
Although some studies have reported the safety of early oral intake after gastrectomy, it still remains controversial. This study focused on the feasibility of a clinical pathway with early oral intake and discharge setting for exclusively laparoscopic distal gastrectomy. A clinical pathway was applied to 403 patients until December 2014. In the protocol, patients are allowed to take a sip of water and a soft diet on the first and second days after the operation, respectively, and the discharge day is set as the fifth to seventh day after the operation. Clinicopathological variables were prospectively collected, and risk factors for discharge variances were analyzed. The completion rate of the clinical pathway was 76.9%. There were five re-admissions (1.2%). The overall morbidity rate was 18% (n = 72), and major complications (Clavien-Dindo IIIa or greater) occurred in 13 patients (3%). Complications were the causes for discharge variances in 68 cases (73%), while the attending surgeons’ judgment was the cause in 25 cases (27%). On multivariate analysis, age (odds ratio = 2.23, 95% confidence interval = 1.38–3.60, p = 0.001) and operative time (odds ratio = 2.38, 95% confidence interval = 1.45–3.98, p = 0.001) were independent risk factors for discharge variances. A high completion rate of a clinical pathway with early oral intake and discharge setting for laparoscopic distal gastrectomy was achievable with an acceptably low re-admission rate. Laparoscopic distal gastrectomy is recommended as a first step for a clinical pathway with an early oral intake and discharge protocol.

1 February 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
TWTakeyuki Wada
Takeyuki Wada
TYTakaki Yoshikawa
Takaki Yoshikawa
SSShigeki Sekine
Shigeki Sekine
AKAyako Kamiya
Ayako Kamiya
THTsutomu Hayashi
Tsutomu Hayashi
HKHitoshi Katai
Hitoshi Katai